Advancing
Medicine Through
Clinical Research Advancing Medicine Through Clinical Research

PharmaC Miami Research is a clinical research site in Miami, Florida, dedicated to advancing medicine through high-quality clinical trials. We collaborate with pharmaceutical, biotechnology, medical device, and clinical research organizations to evaluate investigational therapies, technologies, and medical devices.

Our site supports Phase II–IV clinical research and selected medical device, digital health, observational, and post-market studies. Our areas of interest include primary care, metabolic disorders, obesity, diabetes, CNS/psychiatry, cardiovascular disease, migraine, women’s health, audiology, and other outpatient indications.

We are located in Miami, Florida, serving participants throughout Miami-Dade and the broader South Florida community.

A clinical trial is a research study involving volunteers that evaluates medical treatments, medications, devices, diagnostic methods, or other healthcare interventions.

Clinical trial participation may provide access to investigational treatments or technologies while contributing to research that may improve future medical care. Participation is always voluntary.

Not necessarily. Study-related procedures and investigational treatments are generally provided according to the individual study protocol without being billed to the participant. Requirements vary by study, and our research team will explain any potential costs before enrollment.

Some clinical trials provide compensation for time and travel. Compensation varies by study and is explained during the informed-consent process.

Clinical trials are conducted under detailed research protocols and applicable regulatory and ethical requirements. Before participating, you will receive information about the study’s procedures, potential benefits, risks, and alternatives so you can make an informed decision.

No clinical study can be guaranteed to be risk-free.

Yes. Participation is voluntary, and you may withdraw at any time. Your research team can explain any recommended safety follow-up if you decide to discontinue participation.

Participant privacy and confidentiality are important components of clinical research. Research records are handled according to applicable privacy requirements, the study protocol, and informed-consent documentation.

Yes. PharmaC serves Miami’s diverse community and supports English- and Spanish-speaking participants when permitted by the study and appropriate approved study materials are available.

Eligibility is determined by each clinical trial’s inclusion and exclusion criteria. Our research team can conduct an initial prescreening and, when appropriate, schedule a screening visit.

Depending on the study, screening may include review of your medical history, medications, vital signs, laboratory testing, physical examination, questionnaires, ECGs, or other protocol-required assessments.

Completing screening does not guarantee enrollment because all eligibility requirements must be satisfied.

PharmaC combines an outpatient research environment with access to a diverse South Florida population, bilingual recruitment capabilities, dedicated research personnel, electronic research systems, flexible scheduling, and a sponsor-focused operational model.

Our investigator network and site infrastructure support opportunities across metabolic disease, obesity, diabetes, primary care, CNS/psychiatry, cardiovascular disease, migraine, audiology, women’s health, and selected medical device and digital-health indications.

Study acceptance depends on investigator qualifications, patient access, facility requirements, and protocol-specific capabilities.

Yes. We are interested in appropriately matched medical device studies, including continuous glucose monitoring, wearable technologies, digital health, remote patient monitoring, audiology devices, neuromodulation, diagnostic technologies, and post-market research.

Yes. Our South Florida recruitment strategy includes English- and Spanish-speaking populations.

Recruitment strategies may include our patient and referral networks, physician referrals, community outreach, digital recruitment, database prescreening where permitted, and indication-specific recruitment campaigns.

All recruitment activities are conducted according to applicable protocol, IRB/EC, privacy, and regulatory requirements.

Yes. Our research operations incorporate electronic systems designed to support clinical trial documentation, source workflows, regulatory management, and sponsor/CRO collaboration.

Depending on protocol requirements, our team can evaluate decentralized and hybrid study components, including digital health technologies, wearable devices, electronic patient-reported outcomes, and remote participant engagement.

We prioritize rapid feasibility evaluation and sponsor communication. Actual turnaround and startup timelines depend on protocol complexity, contracting, budgeting, regulatory requirements, investigator availability, and study-specific requirements.

Sponsors, CROs, and biotechnology or medical-device companies can contact our Business Development team directly through our website. Please include the protocol number or synopsis, therapeutic area, anticipated enrollment, and proposed study timeline whenever available.

Yes. We welcome relationships with physicians and healthcare organizations whose patients may be interested in appropriate clinical research opportunities.

Our objective is to conduct protocol-specific research, not interfere with established physician-patient relationships. When appropriate and authorized by the participant, we can coordinate with the participant’s treating healthcare providers.

Potentially. Qualified physicians and healthcare professionals interested in clinical research may contact PharmaC to discuss investigator or Sub-Investigator opportunities. Participation depends on credentials, experience, therapeutic expertise, protocol requirements, sponsor approval, and applicable regulations.

Yes. PharmaC evaluates compliant referral, community-outreach, and recruitment partnerships. All arrangements must comply with applicable research, privacy, ethical, contractual, and regulatory requirements.